- Home
- LGND vs NOVT Comparison
LGND vs NOVT Comparison
Compare LGND & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- NOVT
- Stock Information
- Founded
- LGND 1987
- NOVT 1968
- Country
- LGND United States
- NOVT United States
- Employees
- LGND 68
- NOVT N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- NOVT Industrial Machinery/Components
- Sector
- LGND Health Care
- NOVT Miscellaneous
- Exchange
- LGND Nasdaq
- NOVT Nasdaq
- Market Cap
- LGND 3.2B
- NOVT 3.8B
- IPO Year
- LGND 1992
- NOVT N/A
- Fundamental
- Price
- LGND $205.69
- NOVT $113.40
- Analyst Decision
- LGND Strong Buy
- NOVT Hold
- Analyst Count
- LGND 8
- NOVT 1
- Target Price
- LGND $144.71
- NOVT $133.00
- AVG Volume (30 Days)
- LGND 139.7K
- NOVT 995.8K
- Earning Date
- LGND 08-05-2025
- NOVT 11-03-2025
- Dividend Yield
- LGND N/A
- NOVT N/A
- EPS Growth
- LGND N/A
- NOVT N/A
- EPS
- LGND N/A
- NOVT 1.46
- Revenue
- LGND $181,488,000.00
- NOVT $960,311,000.00
- Revenue This Year
- LGND $18.41
- NOVT $5.06
- Revenue Next Year
- LGND $18.87
- NOVT $6.89
- P/E Ratio
- LGND N/A
- NOVT $77.36
- Revenue Growth
- LGND 53.40
- NOVT 4.07
- 52 Week Low
- LGND $81.74
- NOVT $98.27
- 52 Week High
- LGND $129.90
- NOVT $173.41
- Technical
- Relative Strength Index (RSI)
- LGND 59.63
- NOVT 53.16
- Support Level
- LGND $198.82
- NOVT $98.27
- Resistance Level
- LGND $209.10
- NOVT $113.09
- Average True Range (ATR)
- LGND 7.14
- NOVT 4.78
- MACD
- LGND -0.67
- NOVT 0.29
- Stochastic Oscillator
- LGND 53.60
- NOVT 98.83
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.